ANI Pharmaceuticals | ANIP - Cost Of Sales


ANI Pharmaceuticals reported $119.8M in Cost of Sales for its fiscal quarter ending in June of 2026.





Cost Of Sales Change Date
AbbVie USD 4.29B 73M Jun/2026
ANI Pharmaceuticals USD 119.8M 5.3M Jun/2026
Aurora Cannabis CAD 8.22M 80.38M Mar/2026
Canopy Growth CAD 62.98M 9.91M Mar/2026
Eli Lilly USD 3.27B 309M Jun/2026
Emergent BioSolutions USD 381.2M 226.1M Jun/2023
Heron Therapeutics USD 11.12M 795K Dec/2025
Hikma Pharmaceutical USD 959M 492.5M Dec/2025
Knight Therapeutics CAD 82.22M 1.03M Dec/2025
Nektar Therapeutics USD 4.43M 5.3M Sep/2024
Novartis USD 3.46B 83M Mar/2026
Omeros USD 33.16M 18.52M Jun/2024
Perrigo USD 708.9M 65.2M Jun/2026
Sun Pharmaceuticals INR 37.02B 9.01B Jun/2026
Teva Pharmaceutical Industries USD 1.98B 30M Jun/2026